[New approaches in antibiotic therapies in chronic pulmonary diseases].
Chronic lung diseases are one of the considerable problems in childhood both for physicians and patients. Due to early diagnosis of illness and complications; advances at vaccination methods and antibiotic therapies; life period of patients have been prolonged so not only at childhood but at adults, chronic lung diseases seem to be important healthy problem. One of the most important factors affecting to prognosis of the diseases are concominant infections. This review is an argument of antibiotic usage regimens at cystic fibrosis, bronchiectasis and allergic bronchopulmonary aspergillosis which are the most usual chronic lung diseases seen at childhood and adults.
Celik
Umit
U
Division of Children Infectious Diseases, Department of Children's Health and Diseases, Faculty of Medicine, Cukurova University, Adana, Turkey.
Kocabas
Emine
E
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000188:drug therapy / Q000453:epidemiology; D001987:Bronchiectasis / Q000188:drug therapy / Q000453:epidemiology; D002648:Child; D002908:Chronic Disease; D015897:Comorbidity; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000453:epidemiology; D024881:Drug Resistance, Bacterial; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy* / Q000453:epidemiology*; D011379:Prognosis
D000900:Anti-Bacterial Agents